Show source-provided references
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
10.3322/caac.21660 ↗3. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine
10.1093/jnci/93.4.284 ↗7. Cetina-Pérez, L., Luvián-Morales, J., Delgadillo-González, M., Castro-Eguiluz, D., Galicia-Carmona, T., Rely, K., Vaca González, R., Lugo-Martínez, G., García-Barrientos, N., and Nateras, A. (2024). Sociodemographic characteristics and their association with survival in women with cervical cancer. BMC Cancer, 24.
10.1186/s12885-024-11909-3 ↗8. Survival analysis and associated factors in patients with cervical cancer financed by the Seguro Popular in Mexico
10. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines
12. Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances
10.2147/IJN.S269986 ↗13. Advance in Nanomedicine for Improving Mucosal Penetration and Effective Therapy of Cervical Cancer
10.1002/smll.202303772 ↗15. A review of bismuth-based nanoparticles and their applications in radiosensitising and dose enhancement for cancer radiation therapy
10.1049/nbt2.12134 ↗16. Gomez, C., Hallot, G., Laurent, S., and Port, M. (2021). Medical Applications of Metallic Bismuth Nanoparticles. Pharmaceutics, 13.
10.3390/pharmaceutics13111793 ↗17. Synthesis and characterization of lipophilic bismuth dimercaptopropanol nanoparticles and their effects on oral microorganisms growth and biofilm formation
10.1007/s11051-014-2456-5 ↗18. Antitumor activity of a hydrogel loaded with lipophilic bismuth nanoparticles on cervical, prostate, and colon human cancer cells
10.1097/CAD.0000000000000863 ↗19. Efficacy of cetylpyridinium chloride used as oropharyngeal antiseptic
20. Cetylpyridinium chloride mouth rinses alleviate experimental gingivitis by inhibiting dental plaque maturation
10.1038/ijos.2016.18 ↗22. García-Cuellar, C.M., Hernández-Delgadillo, R., Solis-Soto, J.M., Meester, I., Sánchez-Pérez, Y., Nakagoshi-Cepeda, S.E., Nakagoshi-Cepeda, M.A.A., Chellam, S., and Cabral-Romero, C. (2022). Cetylpyridinium chloride inhibits human breast tumor cells growth in a no-selective way. J. Appl. Biomater. Funct. Mater., 20.
10.1177/22808000221092157 ↗23. García-Cuellar, C.M., Hernández-Delgadillo, R., Torres-Betancourt, J.A., Solis-Soto, J.M., Meester, I., Sánchez-Pérez, Y., Pineda-Aguilar, N., Nakagoshi-Cepeda, S.E., Sánchez-Nájera, R.I., and Nakagoshi-Cepeda, M.A.A. (2023). Cumulative antitumor effect of bismuth lipophilic nanoparticles and cetylpyridinium chloride in inhibiting the growth of lung cancer. J. Appl. Biomater. Funct. Mater., 21.
10.1177/22808000231161177 ↗24. Mucoadhesive 3D printed vaginal ovules to treat endometriosis and fibrotic uterine diseases
25. Study of dissolution profiles and desintegration of capsules containing the dried hydroethanolic extract of Calophyllum brasiliense
10.1590/S0102-695X2012005000145 ↗26. Janeczko, M., and Kochanowicz, E. (2024). Biochanin A Inhibits the Growth and Biofilm of Candida Species. Pharmaceuticals, 17.
10.3390/ph17010089 ↗28. Gonçalves, C.A., Pereira-da-Silva, G., Silveira, R., Mayer, P.C.M., Zilly, A., and Lopes-Júnior, L.C. (2024). Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review. Cancers, 16.
10.3390/cancers16030672 ↗32. Preparation and characterization of mucoadhesive thermoresponsive systems containing propolis for the treatment of vulvovaginal candidiasis
10.1002/jps.23451 ↗34. Women’s experiences, preferences and perceptions regarding vaginal products: Results from a cross-sectional web-based survey in Portugal
10.3109/13625187.2014.980501 ↗36. Rajan, S.S., Chandran, R., and Abrahamse, H. (2024). Overcoming challenges in cancer treatment: Nano-enabled photodynamic therapy as a viable solution. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 16.
10.1002/wnan.1942 ↗37. Biopolymer-based tumor microenvironment-responsive nanomedicine for targeted cancer therapy
10.2217/nnm-2023-0302 ↗38. Khan, H., Shahab, U., Alshammari, A., Alyahyawi, A.R., Akasha, R., Alharazi, T., Ahmad, R., Khanam, A., Habib, S., and Kaur, K. (2024). Nano-therapeutics: The upcoming nanomedicine to treat cancer. IUBMB Life.
10.1002/iub.2814 ↗39. Avgoustakis, K., and Angelopoulou, A. (2024). Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments. Pharmaceutics, 16.
10.3390/pharmaceutics16020179 ↗40. Additive manufacturing in drug delivery: Innovative drug product design and opportunities for industrial application
10.1016/j.addr.2021.113990 ↗41. Mao, X., Calero-Pérez, P., Montpeyó, D., Bruna, J., Yuste, V.J., Candiota, A.P., Lorenzo, J., Novio, F., and Ruiz-Molina, D. (2022). Intranasal Administration of Catechol-Based Pt(IV) Coordination Polymer Nanoparticles for Glioblastoma Therapy. Nanomaterials, 12.
10.3390/nano12071221 ↗42. Petre, I., Sirbu, D.T., Petrita, R., Toma, A.D., Peta, E., and Dimcevici-Poesina, F. (2023). Real-world study of Cerviron(®) vaginal ovules in the treatment of cervical lesions of various etiologies. Biomed. Rep., 19.
10.3892/br.2023.1618 ↗43. Chitosan-hydroxypropyl methylcellulose tioconazole films: A promising alternative dosage form for the treatment of vaginal candidiasis
10.1016/j.ijpharm.2018.12.011 ↗45. Fenticonazole nitrate for treatment of vulvovaginitis: Efficacy, safety, and tolerability of 1-gram ovules, administered as ultra-short 2-day regimen
10.1179/joc.2004.16.2.179 ↗46. Mitofusin-2 Triggers Cervical Carcinoma Cell Hela Apoptosis via Mitochondrial Pathway in Mouse Model
10.1159/000488410 ↗47. Human serum albumin-bound paclitaxel nanoparticle inhibits cervical carcinoma cell proliferation and oxidative damage through CYP3A4 and CYP2C8
10.1016/j.heliyon.2024.e24460 ↗48. Investigation of in-vitro Anti-Cancer and Apoptotic Potential of Garlic-Derived Nanovesicles against Prostate and Cervical Cancer Cell Lines
10.31557/APJCP.2024.25.2.575 ↗